{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:51:55Z","timestamp":1789663915080,"version":"4.0.1"},"publisher-location":"Vienna","reference-count":97,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211333273","type":"print"},{"value":"9783211333280","type":"electronic"}],"license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006]]},"DOI":"10.1007\/978-3-211-33328-0_10","type":"book-chapter","created":{"date-parts":[[2006,12,24]],"date-time":"2006-12-24T04:56:17Z","timestamp":1166936177000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson\u2019s disease induced by the Japanese encephalitis virus"],"prefix":"10.1007","author":[{"given":"M.","family":"Minami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hamaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hirafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hiroshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0891-5849(91)90009-R","volume":"10","author":"J.D. Adams","year":"1991","unstructured":"Adams JD, Odunze IN (1991) Oxygen free radicals and Parkinson\u2019s disease. Free Radical Biol Med 10: 161\u2013169","journal-title":"Free Radical Biol Med"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/mds.870070213","volume":"7","author":"R.S.C. Alves","year":"1992","unstructured":"Alves RSC, Barbosa ER, Scaff M (1992) Postvaccinial parkinsonism. Movement Disorders 7: 178\u2013180","journal-title":"Movement Disorders"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.410320403","volume":"32","author":"S.H. Appel","year":"1992","unstructured":"Appel SH, Le WD, Tajti J, Haverkamp LJ, Engelhardt JI (1992) Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Ann Neurol 32: 494\u2013501","journal-title":"Ann Neurol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0165-1838(84)90011-0","volume":"11","author":"I. Armando","year":"1984","unstructured":"Armando I, Barontini M, Levin G, Simsolo R, Glover V, Sandler M (1984) Exercise increases endogenous urinary monoamine oxidase benzodiazepine receptor ligand inhibitory activity in normal children. J Auton Nerv Syst 11: 95\u2013100","journal-title":"J Auton Nerv Syst"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF01259407","volume":"71","author":"I. Armando","year":"1988","unstructured":"Armando I, Levin G, Barontini M (1988) Stress increases endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in rat tissues. J Neural Transm 71: 29\u201337","journal-title":"J Neural Transm"},{"key":"10_CR6","first-page":"829","volume":"17","author":"S.K. Battacharya","year":"1982","unstructured":"Battacharya SK, Glover V, Sandler M, Clow A, Topham A, Bernadt M, Murray R (1982) Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol. Biol Psychiat 17: 829\u2013836","journal-title":"Biol Psychiat"},{"key":"10_CR7","first-page":"453","volume":"9","author":"S.K. Battacharya","year":"1993","unstructured":"Battacharya SK, Acharya SB (1993) Further investigations on the anxiogenic effects of isatin. Biog Amines 9: 453\u2013463","journal-title":"Biog Amines"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0893-133X(95)00204-Q","volume":"15","author":"S.K. Battacharya","year":"1996","unstructured":"Battacharya SK, Chakrabarti A, Sandler M, Glover V (1996) Anxyolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsycho-pharmacol 15: 199\u2013206","journal-title":"Neuropsycho-pharmacol"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","volume":"35","author":"P.A. Ballard","year":"1985","unstructured":"Ballard PA, Tetrud JW, Langston JW (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35: 949\u2013956","journal-title":"Neurology"},{"key":"10_CR10","first-page":"71","volume":"39","author":"R.C. Bansal","year":"1988","unstructured":"Bansal RC, Kaur P, Kiran R (1988) Mode of interaction of isatin with rat liver alkaline phosphatase. Res Bull (Science) PU Chandigarh 39: 71\u201376","journal-title":"Res Bull (Science) PU Chandigarh"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0301-0082(94)90036-1","volume":"44","author":"M.D. Berry","year":"1994","unstructured":"Berry MD, Juorio AV, Paterson IA (1994) Possible mechanisms of action of (\u2212)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog Neurobiol 44: 141\u2013161","journal-title":"Prog Neurobiol"},{"key":"10_CR12","first-page":"337","volume-title":"The Enzymes","author":"H. Blaschko","year":"1973","unstructured":"Blaschko H (1973) Amine oxidase. In: Boyer PD, Lardy H, Myrback K (eds) The Enzymes. 3rd ed, vol 8, Academic Press, New York, pp 337\u2013351","edition":"3rd ed"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-510X(71)90109-2","volume":"12","author":"S. Bojinov","year":"1971","unstructured":"Bojinov S (1971) Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci 12: 383\u2013415","journal-title":"J Neurol Sci"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"R.S. Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546\u20134550","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/379255a0","volume":"379","author":"M. Bursey","year":"1996","unstructured":"Bursey M, Eichenbaum H (1996) Conservation of hippocampal memory function in rats and humans. Nature 379: 255\u2013257","journal-title":"Nature"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(83)90802-4","volume":"2","author":"D.B. Calne","year":"1983","unstructured":"Calne DB, Langston JW (1983) Aetiology of Parkinson\u2019s disease. Lancet 2: 1457\u20131459","journal-title":"Lancet"},{"key":"10_CR17","first-page":"495","volume":"28","author":"L. Chocholova","year":"1979","unstructured":"Chocholova L, Kolinova M (1979) Effect of isatin on audiogenic seizures in rats and its relationship to electrographic and behavioral phenomena. Physiol Bohemoslov 28: 495\u2013502","journal-title":"Physiol Bohemoslov"},{"key":"10_CR18","first-page":"129","volume":"30","author":"L. Chocholova","year":"1981","unstructured":"Chocholova L, Kolinova M (1981) Effect of isatin (2, 3 dioxyindoline) on physiological and pathological electrographic manifestations of vigilance. Physiol Bohemoslov 30: 129\u2013137","journal-title":"Physiol Bohemoslov"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0024-3205(83)90778-6","volume":"33","author":"A. Clow","year":"1983","unstructured":"Clow A, Glover V, Armando I, Sandler M (1983) New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous MAO inhibitor? Life Sci 33: 735\u2013741","journal-title":"Life Sci"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1192\/bjp.152.1.122","volume":"152","author":"A. Clow","year":"1988","unstructured":"Clow A, Glover V, Weg MW, Walker PL, Sheehan DV, Carr DB, Sandler M (1988a) Urinary catecholamine metabolite and tribulin output during lactate infusion. Br J Psychiatry 152: 122\u2013126","journal-title":"Br J Psychiatry"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00181951","volume":"95","author":"A. Clow","year":"1988","unstructured":"Clow A, Glover V, Sandler M, Tiller J (1988b) Increased urinary tribulin output in generalized anxiety disorder. Psychopharmacol 95: 378\u2013380","journal-title":"Psychopharmacol"},{"key":"10_CR22","first-page":"119","volume":"45","author":"G. Cohen","year":"1986","unstructured":"Cohen G (1986) Monoamine oxidase, hydrogen peroxidase and Parkinson\u2019s disease. Adv Neurol 45: 119\u2013125","journal-title":"Adv Neurol"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"D.T. Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52: 1830\u20131836","journal-title":"J Neurochem"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0002-9343(52)90356-2","volume":"12","author":"R.B. Dickerson","year":"1952","unstructured":"Dickerson RB, Newton JR, Hansen JE (1952) Diagnosis and immediate prognosis of Japanese B encephalitis. Am J Med 12: 277\u2013288","journal-title":"Am J Med"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archneur.1965.00460270003001","volume":"12","author":"R.C. Duvoisin","year":"1965","unstructured":"Duvoisin RC, Yahr MD (1965) Encephalitis and parkinsonism. Arch Neurol 12: 227\u2013239","journal-title":"Arch Neurol"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF01243358","volume":"67","author":"J.D. Elsworth","year":"1986","unstructured":"Elsworth JD, Dewar D, Glover V, Goodwin BL, Clow A, Sandler M (1986) Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and benzodiazepine receptor binding. J Neural Transm 67: 45\u201356","journal-title":"J Neural Transm"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.2992088","volume":"229","author":"P.S. Fishman","year":"1985","unstructured":"Fishman PS, Gass JS, Swoveland PT, Lavi E, Highkin MK, Weiss SR (1985) Infection of the basal ganglia by a murine coronavirus. Science 229: 877\u2013879","journal-title":"Science"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/116.1.281","volume":"116","author":"J.F. Geddes","year":"1993","unstructured":"Geddes JF, Hughes AJ, Lees AJ, Daniel SE (1993) Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 116: 281\u2013302","journal-title":"Brain"},{"issue":"[Suppl 3]","key":"10_CR29","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1212\/WNL.47.6_Suppl_3.137S","volume":"47","author":"M. Gerlach","year":"1996","unstructured":"Gerlach M, Youdim MB, Riederer P (1996) Pharmacology of selegiline. Neurology 47[Suppl 3]: S137\u2013S145","journal-title":"Neurology"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00693789","volume":"73","author":"W.R.G. Gibb","year":"1987","unstructured":"Gibb WRG, Lees AJ (1987) The progression of idiopathic Parkinson\u2019s disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome. Acta Neuropathol (Berl) 73: 195\u2013201","journal-title":"Acta Neuropathol"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0006-2952(80)90534-1","volume":"29","author":"V. Glover","year":"1980","unstructured":"Glover V, Reveley MA, Sandler M (1980) A monoamine oxidase inhibitor in human urine. Biochem Pharmacol 29: 467\u2013470","journal-title":"Biochem Pharmacol"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1471-4159.1988.tb01089.x","volume":"51","author":"V. Glover","year":"1988","unstructured":"Glover V, Halket JM, Watkins PJ, Clow A, Goodwin BL, Sandler M (1988) Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 51: 656\u2013659","journal-title":"J Neurochem"},{"key":"10_CR33","first-page":"1","volume":"29","author":"V. Glover","year":"1991","unstructured":"Glover V, Bhattacharya SK, Sandler M (1991) Isatin-a new biological factor. Indian J Exp Biol 29: 1\u20135","journal-title":"Indian J Exp Biol"},{"issue":"[Suppl]","key":"10_CR34","first-page":"37","volume":"40","author":"V. Glover","year":"1993","unstructured":"Glover V, Clow A, Sandler M (1993) Effects of dopaminergic drugs on superoxide dismutase: implications for senescence. J Neurol Transm 40[Suppl]: 37\u201345","journal-title":"J Neurol Transm"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0024-3205(95)02189-P","volume":"57","author":"V. Glover","year":"1995","unstructured":"Glover V, Medvedev A, Sandler M (1995) Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci 57: 2073\u20132079","journal-title":"Life Sci"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/0024-3205(86)90576-X","volume":"38","author":"J.M. Gorell","year":"1986","unstructured":"Gorell JM, Czarnecki B (1986) Pharmacological evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 38: 2239\u20132246","journal-title":"Life Sci"},{"key":"10_CR37","first-page":"236","volume":"64","author":"A. Goto","year":"1962","unstructured":"Goto A (1962) Follow-up study of Japanese B encephalitis. Psychiat Neurol Jpn (Tokyo) 64: 236\u2013266","journal-title":"Psychiat Neurol Jpn"},{"key":"10_CR38","first-page":"401","volume":"8","author":"N. Hamaue","year":"1992","unstructured":"Hamaue N, Minami M, Kanamaru Y, Togashi M, Monma Y, Ishikura M, Mahara R, Yamazaki N, Togashi H, Saito H, Parvez SH (1992) Endogenous monoamine oxidase (MAO) inhibitor (tribulin-like activity) in the brain and urine of stroke-prone SHR. Biog Amines 8: 401\u2013412","journal-title":"Biog Amines"},{"key":"10_CR39","first-page":"99","volume":"10","author":"N. Hamaue","year":"1994","unstructured":"Hamaue N, Minami M, Kanamaru Y, Ishikura M, Yamazaki N, Saito H, Parvez SH (1994) Identification of isatin, an endogenous MAO inhibitor, in the brain of stroke-prone SHR. Biog Amines 10: 99\u2013110","journal-title":"Biog Amines"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0306-3623(97)00274-7","volume":"30","author":"N. Hamaue","year":"1998","unstructured":"Hamaue N, Yamazaki N, Minami M, Endo T, Hirafuji M, Monma Y, Togashi H (1998) Determination of isatin, an endogenous monoamine oxidase inhibitor, in urine and tissues of rats by HPLC. Gen Pharmacol 30: 387\u2013391","journal-title":"Gen Pharmacol"},{"key":"10_CR41","first-page":"367","volume":"15","author":"N. Hamaue","year":"1999","unstructured":"Hamaue N, Yamazaki N, Minami M, Endo T, Hirafuji M, Monma Y, Togashi H, Saito H, Parvez SH (1999a) Effects of isatin, an endogenous MAO inhibitor, on acetylcholine and dopamine levels in the rat striatum. Biog Amines 15: 367\u2013377","journal-title":"Biog Amines"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1527-3458.1999.tb00109.x","volume":"5","author":"N. Hamaue","year":"1999","unstructured":"Hamaue N, Minami M, Hirafuji M, Terado M, Machida M, Yamazaki N, Yoshioka M, Ogata A, Tashiro K (1999b) Isatin, an endogenous MAO inhibitor, as a new biological modulator. CNS Drug Rev 5: 331\u2013346","journal-title":"CNS Drug Rev"},{"key":"10_CR43","first-page":"63","volume":"108","author":"N. Hamaue","year":"2000","unstructured":"Hamaue N, Yamazaki N, Terado M, Minami M, Ohno K, Ide H, Ogata A, Honma S, Tashiro K (2000) Urinary isatin concentrations in patients with Parkinson\u2019s disease determined by a newly developed HPLC-UV method. Res Commun Mol Pathol Pharmacol 108: 63\u201373","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0161-813X(03)00100-1","volume":"25","author":"N. Hamaue","year":"2004","unstructured":"Hamaue N, Minami M, Terado M, Hirafuji M, Endo T, Machida M, Hiroshige T, Ogata A, Tashiro K, Saito H, Parvez SH (2004) Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson\u2019s disease induced by the Japanese encephalitis virus. NeuroToxicology 25: 205\u2013213","journal-title":"NeuroToxicology"},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"M.M. Hoehn","year":"1967","unstructured":"Hoehn MM, Yarh MD (1967) Parkinsonism: onset, progression and mortality. Neurolol 17: 427\u2013442","journal-title":"Neurolol"},{"key":"10_CR46","first-page":"710","volume":"32","author":"D. Hota","year":"1994","unstructured":"Hota D, Acharya SB (1994) Studies on peripheral actions of isatin. Ind J Exp Biol 32: 710\u2013717","journal-title":"Ind J Exp Biol"},{"key":"10_CR47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"S.M. Hsu","year":"1981","unstructured":"Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577\u2013580","journal-title":"J Histochem Cytochem"},{"key":"10_CR48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0317167100031024","volume":"17","author":"A.J. Hudson","year":"1990","unstructured":"Hudson AJ, Rice GPA (1990) Similarities of Guamanian ALS\/PD to postencephalitic parkinsonism\/ALS: possible viral cause. Can J Neurol Sci 17: 427\u2013433","journal-title":"Can J Neurol Sci"},{"key":"10_CR49","first-page":"557","volume":"266","author":"A. Imperato","year":"1993","unstructured":"Imperato A, Obinu MC, Casu A, Mascia S, Dazzi L, Gessa GL (1993) Evidence that neuroleptics increase striatal acetylcholine release though stimulation of dopamine D1 receptors. J Pharmacol Exp Ther 266: 557\u2013562","journal-title":"J Pharmacol Exp Ther"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01249116","volume":"84","author":"J. Jarman","year":"1991","unstructured":"Jarman J, Przylorowska A, Glover V, Halket J, Davies PT, Rose FC, Sandler M (1991) Urinary output of endogenous monoamine oxidase inhibitor and isatin during acute migraine attack. J Neural Transm Gen Sect 84: 129\u2013134","journal-title":"J Neural Transm Gen Sect"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ana.410180510","volume":"18","author":"R.T. Johnson","year":"1985","unstructured":"Johnson RT, Burke DS, Elwell M, Leake CJ, Nisalak A, Hoke CH, Lorsomrudee W (1985) Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18: 567\u2013573","journal-title":"Ann Neurol"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF01246955","volume":"43","author":"J. Knoll","year":"1978","unstructured":"Knoll J (1978) The possible mechanisms of action of (\u2212)deprenyl in Parkinson\u2019s disease. J Neural Transm 43: 177\u2013198","journal-title":"J Neural Transm"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF03159960","volume":"16","author":"K. Kristensson","year":"1992","unstructured":"Kristensson K (1992) Potential role of viruses in neuro-degeneration. Mol Chem Neuropathol 16: 45\u201358","journal-title":"Mol Chem Neuropathol"},{"key":"10_CR54","first-page":"655","volume":"15","author":"P. Kumar","year":"1977","unstructured":"Kumar P, Dani HM, Trehan S (1977) Effect of isatin testicular hyaluronidase. Ind J Exp Biol 15: 655\u2013656","journal-title":"Ind J Exp Biol"},{"key":"10_CR55","first-page":"281","volume":"9","author":"P. Kumar","year":"1993","unstructured":"Kumar P, Bansal RC, Mahmood A (1993) Isatin, an inhibitor of acetylcholinesterase activity in rat brain. Biog Amines 9: 281\u2013289","journal-title":"Biog Amines"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0306-4522(83)90102-1","volume":"10","author":"J. Lehmann","year":"1983","unstructured":"Lehmann J, Langer SZ (1983) The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? Neurosci 10: 1105\u20131120","journal-title":"Neurosci"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4347(00)82478-0","volume":"526","author":"M. Matsumoto","year":"1990","unstructured":"Matsumoto M, Togashi H, Yoshioka M, Hirokami M, Morii K, Saito H (1990) Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anaesthetized normotensive rats. J Chromatogr 526: 1\u201310","journal-title":"J Chromatogr"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF01250998","volume":"79","author":"I.M. McIntyre","year":"1990","unstructured":"McIntyre IM, Norman TR (1990) Serotonergic effects of isatin: an endogenous MAO inhibitor related to tribulin. J Neural Transm 79: 35\u201340","journal-title":"J Neural Transm"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"P.L. McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24: 574\u2013576","journal-title":"Ann Neurol"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0006-2952(96)00206-7","volume":"52","author":"A.E. Medvedev","year":"1996","unstructured":"Medvedev AE, Clow A, Sandler M, Glover V (1996) Isatin: A link between natriuretic peptides and monoamines? Biochem Pharmacol 52: 385\u2013391","journal-title":"Biochem Pharmacol"},{"key":"10_CR61","first-page":"517","volume":"5","author":"M. Minami","year":"1988","unstructured":"Minami M, Senjo M, Togashi H, Yoshioka M, Saito H, Kawaguchi H, Takebayashi K, Parvez H (1988) Kidney glutathione S-transferase activity and kidney monoamine oxidase activity in stroke cases of SHRSP. Biog Amines 5: 517\u2013526","journal-title":"Biog Amines"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JCM.29.10.2107-2110.1991","volume":"29","author":"K. Morita","year":"1991","unstructured":"Morita K, Tanaka M, Igarashi A (1991) Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol 29: 2107\u20132110","journal-title":"J Clin Microbiol"},{"key":"10_CR63","first-page":"333","volume":"4","author":"M. Muller","year":"1989","unstructured":"Muller M, Schramek J (1989) Combined application of propranolol and local anesthetics: enhanced anticonvulsant action. Biomed Biochim Acta 4: 333\u2013336","journal-title":"Biomed Biochim Acta"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0304-3940(88)90166-8","volume":"87","author":"T. Nagatsu","year":"1988","unstructured":"Nagatsu T, Yoshida M (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primate with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178\u2013182","journal-title":"Neurosci Lett"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0006-8993(92)90886-E","volume":"584","author":"O.G. Nilsson","year":"1992","unstructured":"Nilsson OG, Leanza G, Bjk\u00f6lund A (1992) Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis. Brain Res 584: 132\u2013140","journal-title":"Brain Res"},{"key":"10_CR66","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/JVI.65.2.880-886.1991","volume":"65","author":"A. Ogata","year":"1991","unstructured":"Ogata A, Nagashima K, Hall WW, Ichikawa M, Kimura-Kuroda J, Yasui K (1991) Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol 65: 880\u2013886.","journal-title":"J Virol"},{"key":"10_CR67","first-page":"141","volume":"3","author":"A. Ogata","year":"1997","unstructured":"Ogata A, Tashiro K, Nukuzuma S, Nagashima K, Hall WW (1997) A rat model of Parkinson\u2019s disease induced by Japanese encephalitis virus. J Neurol Virol 3: 141\u2013147","journal-title":"J Neurol Virol"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-510X(98)00150-6","volume":"159","author":"A. Ogata","year":"1998","unstructured":"Ogata A, Nagashima K, Yasui K, Matsuura T, Tashiro K (1998) Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats. J Neurol Sci 159: 135\u2013139","journal-title":"J Neurol Sci"},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-510X(02)00342-8","volume":"206","author":"A. Ogata","year":"2003","unstructured":"Ogata A, Hamaue N, Terado M, Minami M, Nagashima K, Tashiro K (2003) Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson\u2019s disease induced by Japanese encephalitis virus. J Neurol Sci 206: 79\u201383","journal-title":"J Neurol Sci"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1163\/1569391041501979","volume":"18","author":"A. Ogata","year":"2004","unstructured":"Ogata A, Hamaue N, Minami M, Yabe I, Kikuchi S, Sasaki H, Tashiro K (2004) Post-encephalitis parkinsonism: clinical features and experimental model. Biog Amines 18: 339\u2013347","journal-title":"Biog Amines"},{"key":"10_CR71","first-page":"435","volume":"50","author":"N. Ogawa","year":"1985","unstructured":"Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y (1985) A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmaco 50: 435\u2013441","journal-title":"Res Commun Chem Pathol Pharmaco"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/0006-8993(92)90497-W","volume":"572","author":"T. Ohue","year":"1992","unstructured":"Ohue T, Koshimura K, Akiyama Y, Ito A, Kido T, Takagi Y, Miwa S (1992) Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection. Brain Res 572: 340\u2013344","journal-title":"Brain Res"},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/0024-3205(85)90303-0","volume":"37","author":"G. Oxenkrug","year":"1985","unstructured":"Oxenkrug G, McIntyre I (1985) Stress-induced synthesis of melatonin; possible involvement of the endogenous monoamine oxidase inhibitor (tribulin). Life Sci 37: 1743\u20131746","journal-title":"Life Sci"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1471-4159.1973.tb00072.x","volume":"20","author":"H. Parvez","year":"1973","unstructured":"Parvez H, Parvez S (1973) The effects of metopirone and adrenectomy on the regulation of the enzymes monoamine oxidase and catechol-O-methyl transferase in different brain regions. J Neurochem 20: 1011\u20131020","journal-title":"J Neurochem"},{"key":"10_CR75","volume-title":"The rat brain in stereotaxic coordinates","author":"G. Paxinos","year":"1980","unstructured":"Paxinos G, Wason C (1980) The rat brain in stereotaxic coordinates. 2nd ed, New York, Academic Press Inc","edition":"2nd ed"},{"key":"10_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/bjp.140.1.7","volume":"140","author":"H. Peturson","year":"1982","unstructured":"Peturson H, Bhattacharya SK, Glover V, Sandler M, Lader MH (1982) Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiat 140: 7\u201310","journal-title":"Br J Psychiat"},{"key":"10_CR77","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P. Riederer","year":"1989","unstructured":"Riederer P, Sotic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals ferritin, glutathione and ascorbic acid in Parkinsonian brain. J Neurochem 52: 515\u2013520","journal-title":"J Neurochem"},{"key":"10_CR78","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0165-6147(82)91243-3","volume":"3","author":"M. Sandler","year":"1982","unstructured":"Sandler M (1982) The emergence of tribulin. Trends Pharmacol Sci 3: 471\u2013472","journal-title":"Trends Pharmacol Sci"},{"key":"10_CR79","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1016\/0024-3205(82)90679-8","volume":"31","author":"B. Scatton","year":"1992","unstructured":"Scatton B (1992) Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci 31: 2883\u20132890","journal-title":"Life Sci"},{"key":"10_CR80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/251529a0","volume":"251","author":"V.H. Sethy","year":"1974","unstructured":"Sethy VH, van Woert MH (1974) Regulation of striatal acetylcholine concentration by dopamine receptors. Nature 251: 529\u2013530","journal-title":"Nature"},{"key":"10_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00838449","volume":"240","author":"H. Shoji","year":"1993","unstructured":"Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattori F (1993) Japanese encephalitis and parkinsonism. J Neurol 240: 59\u201360","journal-title":"J Neurol"},{"key":"10_CR82","first-page":"256","volume":"22","author":"B. Singh","year":"1977","unstructured":"Singh B, Sharma R, Sareen K, Sareen KN, Sohal MS (1977) Isatin enzyme interaction V. Activation of rat liver acid phosphatase. Enzyme 22: 256\u2013261","journal-title":"Enzyme"},{"key":"10_CR83","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/0006-8993(73)90317-X","volume":"55","author":"H. Stadler","year":"1973","unstructured":"Stadler H, Lloyd KG, Gadea-Ciria M, Bartholini G (1973) Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res 55: 476\u2013480","journal-title":"Brain Res"},{"key":"10_CR84","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0306-4522(92)90027-Y","volume":"47","author":"J.C. Stoof","year":"1992","unstructured":"Stoof JC, Drukarch B, DeBoer P, Westerink BHC, Groenewegen HJ (1992) Regulation of the activity of striatal cholinergic neurons by L-DOPA. Neurosci 47: 755\u2013770","journal-title":"Neurosci"},{"key":"10_CR85","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0042-6822(87)90144-9","volume":"161","author":"H. Sumiyoshi","year":"1987","unstructured":"Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497\u2013510","journal-title":"Virology"},{"key":"10_CR86","first-page":"325","volume":"37","author":"I. Susheela","year":"1969","unstructured":"Susheela I, Singh B, Dani HM, Amma MKP, Sareen K (1969) Enzyme inhibition by isatin I. Inhibition of rat liver xanthine oxidase. Enzymol 37: 325\u2013334","journal-title":"Enzymol"},{"key":"10_CR87","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1084\/jem.181.6.2161","volume":"181","author":"M. Takahashi","year":"1995","unstructured":"Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H (1995) The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 181: 2161\u20132169","journal-title":"J Exp Med"},{"key":"10_CR88","first-page":"5","volume-title":"Monoamine oxidase: its inhibition","author":"K.F. Tipton","year":"1976","unstructured":"Tipton KF, Housy MD, Mantle TJ (1976) The nature and locations of the multiple forms of monoamine oxidase. In: Mary LC (ed) Monoamine oxidase: its inhibition. Elsevier, New York, pp 5\u201331"},{"key":"10_CR89","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0006-2952(98)00199-3","volume":"56","author":"Y. Tozawa","year":"1998","unstructured":"Tozawa Y, Ueki A, Manabe S, Matsushima K (1998) Stress-induced increase in urinary isatin excretion in rats: reversal by both dexamethasone and \u03b1-methyl-p-tyrosine. Biochem Pharmacol 56: 1041\u20131046","journal-title":"Biochem Pharmacol"},{"key":"10_CR90","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF02263480","volume":"1","author":"A. Ueki","year":"1989","unstructured":"Ueki A, Willoughby J, Glover V, Sandler M, Stibbe K, Stern GM (1989) Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson\u2019s disease and other neurological disorders. J Neural Transm 1: 263\u2013268","journal-title":"J Neural Transm"},{"key":"10_CR91","first-page":"581","volume":"30","author":"C. Economo Von","year":"1917","unstructured":"Von Economo C (1917) Encephalitis lethargica. Wien klin Wschr 30: 581\u2013585","journal-title":"Wien klin Wschr"},{"key":"10_CR92","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJM196010132631507","volume":"263","author":"J.H. Walters","year":"1960","unstructured":"Walters JH (1960) Post-encephalitic parkinson syndrome after meningoencephalitis due to coxsackie virus group B, type 2. New Eng J Med 263: 744\u2013747","journal-title":"New Eng J Med"},{"key":"10_CR93","first-page":"250","volume":"338","author":"K. Wedzong","year":"1988","unstructured":"Wedzong K, Limberger N, Spath L, Wichman T, Stare K (1988) Acethylcholine release in rat nucleus accumbens is regulated though dopamine D2-receptor. Naunym-Schmied Arch Pharmacol 338: 250\u2013255","journal-title":"Naunym-Schmied Arch Pharmacol"},{"key":"10_CR94","first-page":"451","volume-title":"Handbook of clinical neurology","author":"M.D. Yahr","year":"1978","unstructured":"Yahr MD (1978) Encephalitis lethargica (Von Economo\u2019s disease, epidemic encephalitis). In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology vol 34 Elsevier, Amsterdam, pp 451\u2013457"},{"key":"10_CR95","first-page":"733","volume":"189","author":"H.Y.T. Yang","year":"1974","unstructured":"Yang HYT, Neff NH (1974) The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J Pharmacol Exp Ther 189: 733\u2013740","journal-title":"J Pharmacol Exp Ther"},{"key":"10_CR96","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3940(90)90768-5","volume":"119","author":"M. Yoshida","year":"1990","unstructured":"Yoshida M, Miwa T, Nagatsu T (1990) Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahy droisoquinoline: the behavioral and biochemical changes. Neurosci Lett 119: 109\u2013113","journal-title":"Neurosci Lett"},{"key":"10_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00969190","volume":"15","author":"A. Yumiler","year":"1990","unstructured":"Yumiler A (1990) The effect of isatin (tribulin) on metabolism of indoles in the rat brain and pineal: in vitro and pineal: in vitro and in vivo studies. Neurochem Res 15: 95\u2013100","journal-title":"Neurochem Res"}],"container-title":["Oxidative Stress and Neuroprotection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-33328-0_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T18:52:43Z","timestamp":1584471163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-33328-0_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"ISBN":["9783211333273","9783211333280"],"references-count":97,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-33328-0_10","relation":{},"subject":[],"published":{"date-parts":[[2006]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}